HEMOSTASIS COAGULATION RESEARCH REAGENTS HUMAN PLASMAS GENETIC DISORDERS
Plasma with Factor V Leiden (homozygous mutation)
Advantages
Minimize test time.
Ready to use.
Informations
The Leiden mutation on factor V induces resistance to active Protein C.
This mutation leads to the replacement at position 506 of an arginine by a glutamine, which affects the site of cleavage of factor V by PCa.
Factor V then loses its role as a cofactor of the C protein system, a coagulation inhibitor system.
Factor V retains its procoagulant properties.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
References
| 6-PPMFVLHO | Vial | 1 x 1.0 mL |
